Abbott Picks AbbVie as Name for Pharmaceutical Spinoff

Abbott Laboratories, the drug and medical-device company that plans to split in two, said its pharmaceutical spinoff will be called AbbVie and will debut by the end of the year.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.